| Mr Michael Bradley Buxton, CRNA | |
|
2121 North Ave, Grand Junction, CO 81501-6428 | |
| (970) 242-0731 | |
| Not Available |
| Full Name | Mr Michael Bradley Buxton |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2121 North Ave, Grand Junction, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902903545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 100788 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Bradley Buxton, CRNA 2125 Sequoia Ct, Grand Junction, CO 81503-1041 Ph: (970) 985-4682 | Mr Michael Bradley Buxton, CRNA 2121 North Ave, Grand Junction, CO 81501-6428 Ph: (970) 242-0731 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced that the company will celebrate the treatment of more than 2 million patients with its mechanical heart valve technology. This milestone, a landmark achievement for prosthetic heart valves, demonstrates the company's commitment to cardiac surgery and improving patient outcomes.
Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows.
Alcresta, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company has signed an agreement with Cystic Fibrosis Foundation Therapeutics (CFFT) to accelerate the development of Alcresta's enzyme-based point-of-care products to support the nutritional status of people with cystic fibrosis (CF).
A protein that undesirably shields a skin poxvirus from the immune system may become the key ingredient in a new topical treatment for inflammatory diseases, say medical researchers at the University of Illinois at Urbana-Champaign.
Agência FAPESP – Developed by Biologix, a startup headquartered in São Paulo, Brazil, a sleep apnea home diagnostic and monitoring system based on the Internet of Things can be used for the remote monitoring of individuals with suspected COVID-19 or mild symptoms of the disease.
› Verified 2 days ago
Mr. John Earl Taylor, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731 | |
Christopher G Mroz, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731 Fax: 970-263-5003 |